DIAGNOSTIC REPORT
MC-2558
PATIENT NAME : BHAVISHKA REF. DOCTOR : DR. MUNISH KAKKAR
CODE/NAME & ADDRESS : C000140271 ACCESSION NO : 0026WE004032 AGE/SEX : 7 Years Female
AISHWARYA DIAGNOSTIC PATIENT ID : BHAVF231220150A DRAWN : 08/05/2023 [Link]
C5-48/111, SECTOR-11, PRATAP NAGAR,KUMBHA
CLIENT PATIENT ID: RECEIVED : 08/05/2023 [Link]
MARG
ABHA NO : REPORTED :08/05/2023 [Link]
JAIPUR 302033
9672721777
Test Report Status Final Results Biological Reference Interval Units
HAEMATOLOGY - CBC
CBC-5, EDTA WHOLE BLOOD
BLOOD COUNTS, EDTA WHOLE BLOOD
HEMOGLOBIN (HB) 11.7 11.5 - 15.5 g/dL
METHOD : PHOTOMETRIC MEASUREMENT
RED BLOOD CELL (RBC) COUNT 4.84 4.0 - 5.2 mil/µL
METHOD : COULTER PRINCIPLE
WHITE BLOOD CELL (WBC) COUNT 3.00 Low 5.0 - 13.0 thou/µL
METHOD : COULTER PRINCIPLE
PLATELET COUNT 170 170 - 450 thou/µL
METHOD : COULTER PRINCIPLE
RBC AND PLATELET INDICES
HEMATOCRIT (PCV) 35.3 35.0 - 45.0 %
METHOD : CALCULATED
MEAN CORPUSCULAR VOLUME (MCV) 72.9 Low 77.0 - 95.0 fL
METHOD : DERIVED PARAMETER FROM RBC HISTOGRAM
MEAN CORPUSCULAR HEMOGLOBIN (MCH) 24.2 pg
METHOD : CALCULATED
MEAN CORPUSCULAR HEMOGLOBIN 33.1 31.0 - 37.0 g/dL
CONCENTRATION(MCHC)
METHOD : CALCULATED
RED CELL DISTRIBUTION WIDTH (RDW) 14.7 High 11.6 - 14.0 %
METHOD : DERIVED PARAMETER FROM RBC HISTOGRAM
MENTZER INDEX 15.1
MEAN PLATELET VOLUME (MPV) 8.9 6.8 - 10.9 fL
METHOD : DERIVED PARAMETER FROM PLATELET HISTOGRAM
WBC DIFFERENTIAL COUNT
NEUTROPHILS 50 37 - 65 %
METHOD : VCS TECHNOLOGY
LYMPHOCYTES 44 28 - 48 %
METHOD : VCS TECHNOLOGY
MONOCYTES 04 3.0 - 6.0 %
METHOD : VCS TECHNOLOGY
EOSINOPHILS 02 0-3 %
METHOD : VCS TECHNOLOGY
Page 1 Of 4
Dr. Madhawi Sharma
"Lab Head
RMC No.- 23499/007220"
View Details View Report
PERFORMED AT :
SRL Ltd
FORTIS ESCORTS HOSPITAL, C/[Link] RANBAXY LTD, JAWAHARLAL NEHRU MARG,MALVIYA NAGAR
JAIPUR, 302017 Patient Ref. No. 26000001906745
RAJASTHAN, INDIA
Tel : 0141-2547000, Fax :
CIN - U74899PB1995PLC045956
DIAGNOSTIC REPORT
MC-2558
PATIENT NAME : BHAVISHKA REF. DOCTOR : DR. MUNISH KAKKAR
CODE/NAME & ADDRESS : C000140271 ACCESSION NO : 0026WE004032 AGE/SEX : 7 Years Female
AISHWARYA DIAGNOSTIC PATIENT ID : BHAVF231220150A DRAWN : 08/05/2023 [Link]
C5-48/111, SECTOR-11, PRATAP NAGAR,KUMBHA
CLIENT PATIENT ID: RECEIVED : 08/05/2023 [Link]
MARG
ABHA NO : REPORTED :08/05/2023 [Link]
JAIPUR 302033
9672721777
Test Report Status Final Results Biological Reference Interval Units
BASOPHILS 00 0-1 %
METHOD : VCS TECHNOLOGY
ABSOLUTE NEUTROPHIL COUNT 1.5 Low 2.0 - 8.0 thou/µL
METHOD : CALCULATED
ABSOLUTE LYMPHOCYTE COUNT 1.32 1.0 - 5.0 thou/µL
METHOD : CALCULATED
ABSOLUTE MONOCYTE COUNT 0.12 Low 0.2 - 1.0 thou/µL
METHOD : CALCULATED
ABSOLUTE EOSINOPHIL COUNT 0.06 Low 0.1 - 1.0 thou/µL
METHOD : CALCULATED
ABSOLUTE BASOPHIL COUNT 0 0.0 - 0.1 thou/µL
METHOD : CALCULATED
NEUTROPHIL LYMPHOCYTE RATIO (NLR) 1.1
METHOD : CALCULATED
BAND (STAB) CELLS 00 0.0 - 5.0 %
METHOD : MICROSCOPY
Interpretation(s)
RBC AND PLATELET INDICES-Mentzer index (MCV/RBC) is an automated cell-counter based calculated screen tool to differentiate cases of Iron deficiency anaemia(>13)
from Beta thalassaemia trait
(<13) in patients with microcytic anaemia. This needs to be interpreted in line with clinical correlation and suspicion. Estimation of HbA2 remains the gold standard for
diagnosing a case of beta thalassaemia trait.
WBC DIFFERENTIAL COUNT-The optimal threshold of 3.3 for NLR showed a prognostic possibility of clinical symptoms to change from mild to severe in COVID positive
patients. When age = 49.5 years old and NLR = 3.3, 46.1% COVID-19 patients with mild disease might become severe. By contrast, when age < 49.5 years old and NLR <
3.3, COVID-19 patients tend to show mild disease.
(Reference to - The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients A.-P. Yang, et al. International Immunopharmacology 84 (2020) 106504
This ratio element is a calculated parameter and out of NABL scope.
Page 2 Of 4
Dr. Madhawi Sharma
"Lab Head
RMC No.- 23499/007220"
View Details View Report
PERFORMED AT :
SRL Ltd
FORTIS ESCORTS HOSPITAL, C/[Link] RANBAXY LTD, JAWAHARLAL NEHRU MARG,MALVIYA NAGAR
JAIPUR, 302017 Patient Ref. No. 26000001906745
RAJASTHAN, INDIA
Tel : 0141-2547000, Fax :
CIN - U74899PB1995PLC045956
DIAGNOSTIC REPORT
MC-2558
PATIENT NAME : BHAVISHKA REF. DOCTOR : DR. MUNISH KAKKAR
CODE/NAME & ADDRESS : C000140271 ACCESSION NO : 0026WE004032 AGE/SEX : 7 Years Female
AISHWARYA DIAGNOSTIC PATIENT ID : BHAVF231220150A DRAWN : 08/05/2023 [Link]
C5-48/111, SECTOR-11, PRATAP NAGAR,KUMBHA
CLIENT PATIENT ID: RECEIVED : 08/05/2023 [Link]
MARG
ABHA NO : REPORTED :08/05/2023 [Link]
JAIPUR 302033
9672721777
Test Report Status Final Results Biological Reference Interval Units
BIOCHEMISTRY
LIVER FUNCTION PROFILE, SERUM
BILIRUBIN, TOTAL 3.89 High UPTO 1.0 mg/dL
METHOD : DIAZONIUM ION, BLANKED (ROCHE)
BILIRUBIN, DIRECT 3.47 High 0.00 - 0.30 mg/dL
METHOD : DIAZOTIZATION
BILIRUBIN, INDIRECT 0.42 0.00 - 0.60 mg/dL
METHOD : CALCULATED PARAMETER
TOTAL PROTEIN 6.1 6.0 - 8.0 g/dL
METHOD : BIURET,SERUM BLANK,ENDPOINT
ALBUMIN 3.6 Low 3.8 - 5.4 g/dL
METHOD : BROMOCRESOL GREEN
GLOBULIN 2.5 2.0 - 4.0 g/dL
Neonates -
Pre Mature:
0.29 - 1.04
METHOD : CALCULATED PARAMETER
ALBUMIN/GLOBULIN RATIO 1.4 1.0 - 2.0 RATIO
METHOD : CALCULATED PARAMETER
ASPARTATE AMINOTRANSFERASE(AST/SGOT) 2764 High 0 - 32 U/L
METHOD : UV WITHOUT PYRIDOXAL-5 PHOSPHATE
ALANINE AMINOTRANSFERASE (ALT/SGPT) 2565 High 0 - 31 U/L
METHOD : UV WITHOUT PYRIDOXAL-5 PHOSPHATE
ALKALINE PHOSPHATASE 259 0 - 300 U/L
METHOD : PNPP - AMP BUFFER
GAMMA GLUTAMYL TRANSFERASE (GGT) 107 High 5 - 36 U/L
METHOD : G-GLUTAMYL-CARBOXY-NITROANILIDE
LACTATE DEHYDROGENASE 785 High 120 - 300 U/L
METHOD : LACTATE -PYRUVATE
Interpretation(s)
LIVER FUNCTION PROFILE, SERUM-
Bilirubin is a yellowish pigment found in bile and is a breakdown product of normal heme catabolism. Bilirubin is excreted in bile and urine, and elevated levels may give
yellow discoloration in [Link] levels results from increased bilirubin production (eg, hemolysis and ineffective erythropoiesis), decreased bilirubin excretion (eg,
obstruction and hepatitis), and abnormal bilirubin metabolism (eg, hereditary and neonatal jaundice). Conjugated (direct) bilirubin is elevated more than unconjugated
(indirect) bilirubin in Viral hepatitis, Drug reactions, Alcoholic liver disease Conjugated (direct) bilirubin is also elevated more than unconjugated (indirect) bilirubin when
there is some kind of blockage of the bile ducts like in Gallstones getting into the bile ducts, tumors &Scarring of the bile ducts. Increased unconjugated (indirect) bilirubin
may be a result of Hemolytic or pernicious anemia, Transfusion reaction & a common metabolic condition termed Gilbert syndrome, due to low levels of the enzyme that
attaches sugar molecules to bilirubin.
AST is an enzyme found in various parts of the body. AST is found in the liver, heart, skeletal muscle, kidneys, brain, and red blood cells, and it is commonly measured
clinically as a marker for liver health. AST levels increase during chronic viral hepatitis, blockage of the bile duct, cirrhosis of the liver,liver cancer,kidney failure,hemolytic
Page 3 Of 4
Dr. Madhawi Sharma
"Lab Head
RMC No.- 23499/007220"
View Details View Report
PERFORMED AT :
SRL Ltd
FORTIS ESCORTS HOSPITAL, C/[Link] RANBAXY LTD, JAWAHARLAL NEHRU MARG,MALVIYA NAGAR
JAIPUR, 302017 Patient Ref. No. 26000001906745
RAJASTHAN, INDIA
Tel : 0141-2547000, Fax :
CIN - U74899PB1995PLC045956
DIAGNOSTIC REPORT
MC-2558
PATIENT NAME : BHAVISHKA REF. DOCTOR : DR. MUNISH KAKKAR
CODE/NAME & ADDRESS : C000140271 ACCESSION NO : 0026WE004032 AGE/SEX : 7 Years Female
AISHWARYA DIAGNOSTIC PATIENT ID : BHAVF231220150A DRAWN : 08/05/2023 [Link]
C5-48/111, SECTOR-11, PRATAP NAGAR,KUMBHA
CLIENT PATIENT ID: RECEIVED : 08/05/2023 [Link]
MARG
ABHA NO : REPORTED :08/05/2023 [Link]
JAIPUR 302033
9672721777
Test Report Status Final Results Biological Reference Interval Units
anemia,pancreatitis,hemochromatosis. AST levels may also increase after a heart attack or strenuous [Link] test measures the amount of this enzyme in the [Link]
is found mainly in the liver, but also in smaller amounts in the kidneys,heart,muscles, and [Link] is commonly measured as a part of a diagnostic evaluation of
hepatocellular injury, to determine liver [Link] levels increase during acute hepatitis,sometimes due to a viral infection,ischemia to the liver,chronic
hepatitis,obstruction of bile ducts,cirrhosis.
ALP is a protein found in almost all body [Link] with higher amounts of ALP include the liver,bile ducts and [Link] ALP levels are seen in Biliary obstruction,
Osteoblastic bone tumors, osteomalacia, hepatitis, Hyperparathyroidism, Leukemia, Lymphoma, Pagets disease,Rickets,Sarcoidosis etc. Lower-than-normal ALP levels seen
in Hypophosphatasia,Malnutrition,Protein deficiency,Wilsons disease.
GGT is an enzyme found in cell membranes of many tissues mainly in the liver,kidney and [Link] is also found in other tissues including intestine,spleen,heart, brain
and seminal [Link] highest concentration is in the kidney,but the liver is considered the source of normal enzyme [Link] GGT has been widely used as an
index of liver [Link] serum GGT activity can be found in diseases of the liver,biliary system and [Link] that increase serum GGT are obstructive
liver disease,high alcohol consumption and use of enzyme-inducing drugs etc.
Total Protein also known as total protein,is a biochemical test for measuring the total amount of protein in [Link] in the plasma is made up of albumin and
[Link]-than-normal levels may be due to:Chronic inflammation or infection,including HIV and hepatitis B or C,Multiple myeloma,Waldenstroms
[Link]-than-normal levels may be due to: Agammaglobulinemia,Bleeding (hemorrhage),Burns,Glomerulonephritis,Liver disease, Malabsorption,Malnutrition,Nephrotic
syndrome,Protein-losing enteropathy etc.
Albumin is the most abundant protein in human blood [Link] is produced in the [Link] constitutes about half of the blood serum [Link] blood albumin levels
(hypoalbuminemia) can be caused by:Liver disease like cirrhosis of the liver, nephrotic syndrome,protein-losing enteropathy,Burns,hemodilution,increased vascular
permeability or decreased lymphatic clearance,malnutrition and wasting etc
**End Of Report**
Please visit [Link] for related Test Information for this accession
CONDITIONS OF LABORATORY TESTING & REPORTING
1. It is presumed that the test sample belongs to the patient 5. SRL confirms that all tests have been performed or
named or identified in the test requisition form. assayed with highest quality standards, clinical safety &
2. All tests are performed and reported as per the technical integrity.
turnaround time stated in the SRL Directory of Services. 6. Laboratory results should not be interpreted in isolation;
3. Result delays could occur due to unforeseen it must be correlated with clinical information and be
circumstances such as non-availability of kits / equipment interpreted by registered medical practitioners only to
breakdown / natural calamities / technical downtime or any determine final diagnosis.
other unforeseen event. 7. Test results may vary based on time of collection,
4. A requested test might not be performed if: physiological condition of the patient, current medication or
i. Specimen received is insufficient or inappropriate nutritional and dietary changes. Please consult your doctor
ii. Specimen quality is unsatisfactory or call us for any clarification.
iii. Incorrect specimen type 8. Test results cannot be used for Medico legal purposes.
iv. Discrepancy between identification on specimen 9. In case of queries please call customer care
container label and test requisition form (91115 91115) within 48 hours of the report.
.
SRL Limited
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062
Page 4 Of 4
Dr. Madhawi Sharma
"Lab Head
RMC No.- 23499/007220"
View Details View Report
PERFORMED AT :
SRL Ltd
FORTIS ESCORTS HOSPITAL, C/[Link] RANBAXY LTD, JAWAHARLAL NEHRU MARG,MALVIYA NAGAR
JAIPUR, 302017 Patient Ref. No. 26000001906745
RAJASTHAN, INDIA
Tel : 0141-2547000, Fax :
CIN - U74899PB1995PLC045956
